Suzhou-Based Medical Device Innovator Ensurge Secures RMB 100 Million in Latest Financing Round
Ensurge, a cutting-edge medical device manufacturer headquartered in Suzhou, is reportedly in the spotlight for...
Deals
ImmuneOnco Receives USD 10 Million Upfront Payment from Instil Bio Subsidiary for Licensing Deal
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) has received a USD 10 million upfront payment...
Ocumension Therapeutics to Repurchase Shares, Demonstrating Confidence and Commitment to Investor Rights
Ocumension Therapeutics, a biopharmaceutical company based in China and listed on the Hong Kong Stock...
Novartis and Versant Ventures Launch Borealis Biosciences with a Focus on RNA Medicines for Kidney Diseases
Novartis (NYSE: NVS), a Swiss pharmaceutical heavyweight, has joined forces with the US venture capital...
GSC to Distribute Hecin’s Innovative PCR and RT-PCR Solutions in Middle Eastern Markets
Gulf Scientific Corporation (GSC), a prominent life sciences service provider headquartered in Dubai, United Arab...
Changchun GeneScience Pharmaceutical Expands Reach with HuChuang Union Partnership
Changchun GeneScience Pharmaceutical Co., Ltd, a Chinese pharmaceutical enterprise, has established a partnership with HuChuang...
SynthAsia and Shanghai General Hospital Partner to Advance Diabetic Retinopathy Research
SynthAsia has forged a strategic partnership with Shanghai General Hospital, focusing on scientific innovation within...
Henlius Biotech Secures Exclusive Rights to Commercialize Convalife’s Generic Neratinib in China and Abroad
Shanghai Henlius Biotech Inc., (HKG: 2696), a leading biopharmaceutical company based in China, has entered...
Bone Index Secures Financing to Expand Manufacturing and Promote Diagnostic Technology Globally
Bone Index, a Finland-based medical technology company specializing in bone diagnostics, has announced the successful...
Johnson & Johnson to Acquire Israeli Cardiovascular Device Maker V-Wave for Upfront USD 600 Million
Johnson & Johnson (NYSE: JNJ), a multinational healthcare conglomerate based in the US, has announced...
Shanghai Henlius Biotech Secures Exclusive Rights to Convalife Pharmaceuticals’ Generic Neratinib in China
SHANGHAI—Shanghai Henlius Biotech Inc., (HKG: 2696), a leading biopharmaceutical company based in China, has entered...
Finland’s Bone Index Partners with Lynx Financial for APAC and North American Market Expansion
HELSINKI—Bone Index, a pioneering medical technology company headquartered in Finland, has announced the successful completion...
Johnson & Johnson to Acquire Israel’s V-Wave Ltd. in a Deal Valued Up to $1.7 Billion
NEW YORK—Johnson & Johnson (NYSE: JNJ), a multinational healthcare giant based in the US, has...
Sichuan Kelun Pharmaceutical’s H1 2024 Report Highlights MSD Collaboration Milestones
CHENGDU—Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) has released its financial report for the first...
Jiangsu Hengrui Pharmaceuticals Expands R&D Footprint with Jinan Innovation Zone Partnership
JINAN—The management committee of the Jinan Innovation Zone has entered into a strategic partnership with...
Genesis MedTech’s J-VALVE System Transfers to Edwards Lifesciences, Marking a New Era in Aortic Valve Treatment
SINGAPORE—In a strategic move to strengthen its position in the global medical device market, Edwards...
Multitude Therapeutics and Adcendo ApS Partner on Anti-TF ADC, Targeting Global Cancer Treatment
SHANGHAI/COPENHAGEN—In a strategic move to bolster cancer treatment options, Shanghai-based medical technology company Multitude Therapeutics...
Ant Group Eyes Acquisition of Leading Internet Healthcare Platform Haodf.com
Ant Group, the China-based fintech powerhouse, is reportedly pursuing the acquisition of Haodf.com, one of...
Bio-Thera Solutions Expands Reach with New Licensing Deal for Biosimilar BAT2306
Guangzhou-based Bio-Thera Solutions (SHA: 688177) has entered into a new licensing agreement with Russian firm...
Huadong Medicine Secures Licensing Deal with IMBiologics for Autoimmune Drug Candidates
Huadong Medicine Co., Ltd. (SHE: 000963), a Chinese pharmaceutical company, has entered into a licensing...